Owner Yamanouchi Pharmaceutical Co., Ltd.

Inventors Sugasawa, Keizo; Kadokura, Takeshi; Hirayama, Fukushi; Shigenaga, Takeshi; Ishihara, Tsukasa; Koga, Yuji

Agent Davies Collison Cave

Pub. Number AU-B-2002224064

PCT Pub. Number WO02/42270

Priority 2000-390321 22.12.00 JP; 2000-356146 22.11.00 JP

Filing date 21 November 2001

Wipo publication date 3 June 2002

Acceptance publication date 8 December 2005

C07D 211/26 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/501 - not condensed and containing further heterocyclic rings

A61K 031/4545

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 031/7052

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/706

C07H 015/26 Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61K 031/454

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 009/10 Drugs for disorders of the cardiovascular system

A61K 031/506 - not condensed and containing further heterocyclic rings

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine